TIANGEN, a high-tech biological enterprise, demonstrated its revolutionary nucleic acid extraction solution at Cell Bio 2022, the joint meeting of the American Society for Cell Biology (ASCB) and...

Byrna Technologies Inc. (NASDAQ: BYRN) ("Byrna" or "the Company") today announced preliminary revenue expectations for its fiscal fourth quarter ended November 30, 2022 ("Q4 FY2022") of $16.0...

ReImagine Science, a non-profit focused on transforming the way science is done, is innovating once again with a workshop co-designed with a renowned member of the North American First Nations....

Industry-leading Indices Available with Athene® BCA® Result in Award SCOTTSDALE, Ariz., Dec. 6, 2022 /PRNewswire/ -- Annexus, a leading retirement product design company, announced that Athene...

CEO Eric Finzi and COO Sebastian De Beurs to present on company's innovative neuromodulators for mental health at annual healthcare conference NEWPORT BEACH, Calif., Dec. 6, 2022 /PRNewswire/ --...

P-MUC1C-ALLO1 and P-BCMA-ALLO1 were well tolerated, with no dose-limiting toxicities (DLTs), cytokine release syndrome (CRS), graft vs host disease (GVHD) or immune effector cell-associated...

Nicholas Natasi, a student at Rowan University, won first place and $8,000 at the 39th annual Collegiate Entrepreneurs' Organization (CEO) Conference and Pitch Competition held on Oct. 28-30 in...

-- Fifteen abstracts underscore AbbVie's commitment to people living with migraine -- AbbVie to present late-breaking data from the Chronic Migraine Epidemiology and Outcomes – International...

Adagrasib in combination with pembrolizumab demonstrates favorable tolerability and promising preliminary efficacy in patients with first-line advanced/metastatic NSCLC harboring a KRASG12C...

This week's "Luxury Hour" event will feature important insights from five of the world's most respected experts NEW YORK, Dec. 5, 2022 /PRNewswire/ -- What's in store for luxury real estate...